Medicine guide
MYFEMBREE
As listed in the register: MYFEMBREE
40 mg + 1 mg + 0.5 mg · tablet
- Prescription only
- Hormones, such as thyroid and steroids
- Active substance
- Relugolix + Estradiol + Norethindrone Acetate
- Made by
- Knight Therapeutics Inc.
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Medicine groupHormones, such as thyroid and steroidsH01CC54
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
Details
| Made by | Knight Therapeutics Inc. |
|---|---|
| Active substance | Relugolix + Estradiol + Norethindrone Acetate |
| Used in | Hormones, such as thyroid and steroids |
| Strength | 40 mg + 1 mg + 0.5 mg |
| Form | tablet |
| Classification | H01CC54 · Hormones, such as thyroid and steroids |
| Route | oral |
| Dispensing (as stated by the register) | PRESCRIPTION |
| Status | Marketed |
| Marketed | Yes, according to the register |
| DIN | 02541742 |
| DPD drug code | 103029 |
Source: Drug Product Database · 2026-09-30 · not reviewed by a clinician
Contains information licensed under the Open Government Licence – Canada. Reuse terms: Open Government Licence – Canada.